Zhou, C., Jiang, J., Xiang, X., Liu, H., Wu, G., Zeng, R., . . . Zhang, J. (2024, October). Preclinical investigations and a first-in-human phase 1a trial of JS007, a novel anti-CTLA-4 antibody, in patients with advanced solid tumors. Experimental Hematology & Oncology.
Chicago Style (17th ed.) CitationZhou, Chenfei, et al. "Preclinical Investigations and a First-in-human Phase 1a Trial of JS007, a Novel Anti-CTLA-4 Antibody, in Patients with Advanced Solid Tumors." Experimental Hematology & Oncology Oct. 2024.
MLA (9th ed.) CitationZhou, Chenfei, et al. "Preclinical Investigations and a First-in-human Phase 1a Trial of JS007, a Novel Anti-CTLA-4 Antibody, in Patients with Advanced Solid Tumors." Experimental Hematology & Oncology, Oct. 2024.
Warning: These citations may not always be 100% accurate.